Effects of ONO-3708, an antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on platelet aggregation and thrombosis
- 1 April 1989
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 163 (2-3), 253-261
- https://doi.org/10.1016/0014-2999(89)90194-5
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Inhibition of human platelet aggregation and cytoplasmic calcium response by calcium antagonists: studies with aequorin and quin2.Circulation Research, 1986
- Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548)Thrombosis Research, 1986
- Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581Journal of Neurosurgery, 1982
- Electrical induction of coronary artery thrombosis in the ambulatory canine: A model for evaluation of anti-thrombotic agentsThrombosis Research, 1980
- pA2 and receptor differentiation: A statistical analysis of competitive antagonismLife Sciences, 1979
- Experimental ischemic heart disease—Effects of synthetic thromboxane A2Experimental and Molecular Pathology, 1979
- Platelet and Blood Vessel Arachidonate Metabolism and InteractionsJCI Insight, 1979
- An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissueBiochemical Medicine, 1977
- Thromboxanes: Selective Biosynthesis and Distinct Biological PropertiesScience, 1976
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962